Stocks
G1 Therapeutics (GTHX) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -129.0 | -96.1 | -142.8 | -134.9 | -39.0 | -21.2 | ||
| Changes by years, y/y, % | +45% | -26% | +49% | -6% | -71% | -15.3% | |||
G1 Therapeutics. EBITDA US GAAP, bln rub
G1 Therapeutics. EBITDA US GAAP, changes, %
G1 Therapeutics. EBITDA US GAAP, sum by quarters, bln rub
G1 Therapeutics (GTHX) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -24.5 | 12.9 | -16.4 | -8.81 | -8.93 | -21.2 | |
| Changes by years, y/y, % | -48% | -135% | -23% | -71% | -64% | |||
| Changes by quarters, q/q, % | -18% | -152% | -227% | -46% | +1% | |||
